Trius amends IPO

Trius Therapeutics Inc. (San Diego, Calif.) amended its IPO and now hopes to raise $50 million through the sale of 10 million shares at $5. The price would value the company at $117.8 million. Trius amended the IPO in February to sell 6 million shares at $12-$14. A $13 price would have raised $78 million and valued the company at $216.3 million. The company filed last November to raise up to $86.3 million. The IPO is underwritten by Citigroup; Piper Jaffray; Canaccord; and JMP Securities. ...